ÀÏÀß·¯Ã¤¿ë°ü
ä¿ëÁ¤º¸
ÀÎÀç°Ë»ö
±³À°Á¤º¸
ÇìµåÇåÆÃ
½º¸¶Æ®Å¸¿î
ȸ¿ø¼­ºñ½º
À̷¼­ µî·Ï
ä¿ë°ø°í µî·Ï

Medical Science Liaison for Specialty Medicine ä¿ë°ø°í

¾÷Á¾ ÀÇ·á/Á¦¾à/°Ç°­ ÀÚº»±Ý
±â¾÷ÇüÅ ¿Ü±¹±â¾÷ ¸ÅÃâÇöȲ
´ëÇ¥ÀÚ »ç¿ø¼ö
ȸ»çÁÖ¼Ò ¼­¿ï µ¿ÀÛ±¸ ½Å´ë¹æµ¿ 395-62 »ï¼ºº¸¶ó¸Å ¿È´ÏŸ¿ö
  • ÇöÀç ä¿ëÁ¤º¸¸¦ º¹»çÇÕ´Ï´Ù.
  • ÇöÀç ä¿ëÁ¤º¸¸¦ ÇÁ¸°ÆÃÇÕ´Ï´Ù.




Á÷Á¾ ¿¬±¸°³¹ß¡¤R&D, º¸°Ç¡¤ÀÇ·á
±Ù¹«ÇüÅ Á¤±ÔÁ÷ ä¿ëÁ÷±Þ -
¸ðÁýÀοø 0 ¸í ³ªÀÌ Á¦ÇѾøÀ½
°æ·Â °æ·Â ±Þ¿©Á¶°Ç ´ç»ç±ÔÁ¤
Çз ´ëÁ¹ ÀÌ»ó Á¢¼ö±â°£ Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù
 [ȨÆäÀÌÁöÁ¢¼ö]

Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù

* ´ã´ç¾÷¹«
»ó¼¼Á¶°Ç









 


 


 


¡Ü ¸ðÁýºÎ¼­ ¹× ±âÇÑ


 


 











¸ðÁýºÎ¼­


¸ðÁý±âÇÑ


Medical


2014-11-03 ~ 2014-11-10

















 


 


 


¡Ü ¾÷¹«°³¿ä


 


¡Û Build scientific relationships early development forward with Medical Thought Leaders (MTL) and stakeholders to build advocacy


1.       Contributes to mapping/ profiling of MTLs/ stakeholders in line with segmentation


2.       Develop professional relationships, build advocacy and gain contributions of MTL/stakeholders


3.       Collect, analyze and report insights that may impact development plans / trial designs


4.       Provide and discuss scientific information and data to healthcare professionals to ensure quality and accuracy of medical and scientific information on new treatment options and selected areas of therapeutic interest.


5.       Liaise and provide up-to-date medical support to relevant external groups to facilitate listing of products in medical guidelines, formularies to impact pricing and health-economic discussions.


6.       Provide speaker training to healthcare professionals to support the best use of new therapies developed and commercialized by BHC Pharmaceuticals


 


 


¡Û       Strategically prepare and support the development, launch and commercialization of      BHC Pharmaceuticals products


1.       Contribute to the identification of appropriate clinical investigators and facilitates placement into BHC Pharmaceuticals investigator sponsored studies (ISS).


2.       Identify clinical investigators with research proposals that are consistent with product strategies and facilitate the Investigator sponsored study process as an ISS responsible including study completion, presentation, and publication.


3.       Communicate with regional or global medical affairs to ensure proper ISS strategies and address study-related issues.


4.       Collaborate with marketing and study operation team in the medical department to support conducting various company sponsored studies, investigators¡¯ meeting or presentation at local congresses.


5.       Collaborate with marketing and sales team to actively support medical and scientific activities 


6.       Evaluate the impact of competitive information to share internally and externally in collaboration with Medical Information Team.


 


III.            Provide medical/scientific support internally  


     Provide medical training (i.e. disease, product, new publication, competitors, etc) to both non-medical and medical functions


 


IV.            Comply with Pharmaceutical regulations and Bayer HealthCare Ethical Business Practices


 


 


 


¡Ü ÀÀ½ÃÀÚ°Ý


 


¡Û Background 


- MD, Pharmacist, Nurse, Veterinarian, PhD of biomedical science


 


¡Û  Experience & knowledge 


- At least 1~2 years of experience in Pharma, preferably medical affairs or clinical research and development


 


¡Û  Core competencies & skills 


- Proactive self-leadership


- Leadership and interpersonal skills


- Excellent communication skill including negotiation and persuasion


- Eager learning attitude with scientific expertise


- Fluent in spoken and written English



 


 


 


 


¡ÜÁö¿ø¹æ¹ý


 


¡Û´ç»ç ȨÆäÀÌÁö Áö¿ø


 


 


 


 


 



* ÀÔ»çÁö¿ø ½Ã Áß¿ä»çÇ×À» ²À üũÇϼ¼¿ä!

* ±Ù¹«È¯°æ
±Ù¹«Áö¿ª : ¼­¿ï
±Þ¿©Á¶°Ç : ´ç»ç±ÔÁ¤
* Á¢¼ö°³¿ä

¿À´Ã¸¶°¨

Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù

¡á Á¢¼ö±â°£   ¡á ¿À´Ã   ¡á ¸¶°¨

2014. 11

  • ÀÏ
  • ¿ù
  • È­
  • ¼ö
  • ¸ñ
  • ±Ý
  • Åä
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
* ´ã´çÀÚ Á¤º¸
¸ðÁý±â°£ÀÌ Áö³­ ä¿ëÁ¤º¸ÀÇ °æ¿ì ´ã´çÁ¤º¸´Â °ø°³µÇÁö ¾Ê½À´Ï´Ù.
ÇöÀç ä¿ëÁ¤º¸¸¦ º¹»çÇÕ´Ï´Ù. ÇöÀç ä¿ëÁ¤º¸¸¦ ÇÁ¸°ÆÃÇÕ´Ï´Ù.

µî·Ï : 2014³â 11¿ù 4ÀÏ (È­) 15:10    ÃÖÁ¾¼öÁ¤ : 2014³â 11¿ù 4ÀÏ (È­) 15:10

º» Á¤º¸´Â ¹ÙÀÌ¿¤ÄÚ¸®¾Æ ¿¡¼­ Á¦°øÇÑ ÀÚ·áÀ̸ç, ½ºÄ«¿ìÆ®Àº(´Â) ±× ³»¿ë»óÀÇ ¿À·ù ¹× Áö¿¬, ±× ³»¿ëÀ» ½Å·ÚÇÏ¿© ÃëÇØÁø Á¶Ä¡¿¡ ´ëÇÏ¿© Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. º» Á¤º¸´Â ½ºÄ«¿ìÆ®ÀÇ µ¿ÀÇ ¾øÀÌ Àç¹èÆ÷ÇÒ ¼ö ¾ø½À´Ï´Ù.

¢À ½ºÄ«¿ìÆ® ¿¡¼­´Â °ÅÁþ ±¸ÀÎ ±¤°í¿¡ ´ëÇÑ ÇÇÇØ¸¦ ÃÖ¼ÒÈ­ Çϱâ À§ÇÏ¿© ÇãÀ§ ä¿ë°ø°í¿¡ ½Å°íÁ¦µµ¸¦ ½ÃÇàÇϰí ÀÖ½À´Ï´Ù.
°ÅÁþ±¸Àα¤°í¿¡ ´ëÇÑ ±¸Á÷ÀÚÁÖÀÇ»çÇ× ½Å°íÆ÷»ó±ÝÁ¦ ¾È³» ÇãÀ§ ä¿ë°ø°í ½Å°íÇϱâ

±Ù¹«Áö À§Ä¡ º¸±â

±Ù¹«Áö ÁÖ¼Ò

¼­¿ï µ¿ÀÛ±¸ ½Å´ë¹æµ¿ 395-62 »ï¼ºº¸¶ó¸Å ¿È´ÏŸ¿ö

Å©°Ôº¸±â

[ƯÁý±âȹ] ¹ý·ü»ç¹«Á÷

Á÷¾÷µ¸º¸±â

¹ý·ü»ç¹«Á÷À̶õ?º¯..

¸éÁ¢ helper

¸éÁ¢Áú¹®

Àμº ¡Ú¡Ú¡Ú¡Ú
Àû¼º ¡Ú¡Ú¡Ú¡Ú

Special Interview

½ºÆä¼ÈÀÎÅͺä
¹ý·ü »ç¹«Á÷À̶ó´Â ÀÏÀÌ ¾î¶² ÀÏÀÎÁö Àß ¸ð..